Key result
Fluid redistribution from disturbed ventricular-vascular coupling drives hypertensive AHF, requiring nitrovasodilators.
This review highlights the pathophysiology of hypertensive acute heart failure, emphasizing the role of ventricular-vascular coupling and acute fluid redistribution.
May prioritize nitrovasodilators in hypertensive AHF; extends phenotype-specific insights but leaves open novel therapy efficacy.
While acute heart failure (AHF) is often regarded as a single disorder, an evolving understanding recognises the existence of multiple phenotypes with varied pathophysiological alterations. Herein we discuss hypertensive AHF and provide insight into a mechanism where acute fluid redistribution is caused by a disturbance in the ventricular-vascular coupling relationship. In this relationship, acute alterations in vascular elasticity, vasoconstriction and reflected pulse waves lead to increases in cardiac work and contribute to decompensated LV function with associated subendocardial ischaemia and end-organ damage. Chronic predisposing factors (neurohormonal activity, nitric oxide insensitivity, arterial stiffening) and physiological stressors (sympathetic surge, volume overload, physical exertion) that are causally linked to acute symptom onset are discussed. Lastly, we review treatment options including both nitrovasodilators and promising novel therapeutics, and discuss future directions in the management of this phenotypic variant.
No takes yet. Share an insight, caveat, or question.
Viau et al. (2015) conducted a review in Hypertensive acute heart failure. Hypertensive acute heart failure is driven by acute fluid redistribution due to disturbed ventricular-vascular coupling, with management relying on nitrovasodilators and emerging novel therapeutics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: